Log In
Print
BCIQ
Print
Print this Print this
 

Undisclosed plasma-derived product (C1-INH)

  Manage Alerts
Collapse Summary General Information
Company ProMetic Life Sciences Inc.
DescriptionPlasma-derived blood protein C1 esterase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard Indication Hematology (unspecified)
Indication DetailsTreat Type I plasminogen deficiency (hypoplasminogenemia)
Regulatory Designation

U.S. - Orphan Drug (Treat Type I plasminogen deficiency (hypoplasminogenemia))

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today